We do not publish a verdict for Medifast Inc (MED) and Rollins Inc (ROL) is overvalued.
We publish an intrinsic value for ROL but not for MED, so the two cannot be ranked on price.
Values as of the 22 Sept 2026 close.
We do not publish a value for this company: there is no balance sheet on file to value what it owns.
Leak Score 0/100 on 1 of 12 signals
Discounting its cash flows at 8.7% (average of 3 methods) values the shares at $22.51; the price of $32.86 is 46% above that value, and 77% of that value comes from beyond year five.
Leak Score 59/100 on 3 of 12 signals
| Metric | MED | ROL |
|---|---|---|
| Verdict | Not valued | Overvalued |
| Price | $12.08 | $32.86 |
| Intrinsic value | — | $22.51 |
| Margin of safety | — | -46% |
| Leak Score | 0/100 (1/12) | 59/100 (3/12) |
| Market cap | $135M | $15.8B |
| Revenue growth, 5 years | -16.2% | 11.7% |
| Operating margin | -5.5% | 18.9% |
| Net margin | -8.1% | 13.6% |
| Return on equity | -12.4% | 37.0% |
| Debt to equity | 0.14 | 0.78 |
| P/E | — | 29.8x |
| Forward P/E | — | 25.6x |
| P/B | 0.7x | 11.1x |
| Dividend yield | — | 2.3% |